"Inflammation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
Descriptor ID |
D007249
|
MeSH Number(s) |
C23.550.470
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammation".
Below are MeSH descriptors whose meaning is more specific than "Inflammation".
This graph shows the total number of publications written about "Inflammation" by people in this website by year, and whether "Inflammation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 1 | 3 |
1996 | 0 | 5 | 5 |
1997 | 0 | 3 | 3 |
1998 | 0 | 6 | 6 |
1999 | 2 | 2 | 4 |
2000 | 1 | 4 | 5 |
2001 | 2 | 5 | 7 |
2002 | 5 | 8 | 13 |
2003 | 2 | 12 | 14 |
2004 | 10 | 11 | 21 |
2005 | 10 | 16 | 26 |
2006 | 11 | 23 | 34 |
2007 | 13 | 20 | 33 |
2008 | 7 | 13 | 20 |
2009 | 16 | 14 | 30 |
2010 | 12 | 15 | 27 |
2011 | 26 | 26 | 52 |
2012 | 15 | 28 | 43 |
2013 | 14 | 26 | 40 |
2014 | 20 | 22 | 42 |
2015 | 19 | 26 | 45 |
2016 | 16 | 33 | 49 |
2017 | 21 | 25 | 46 |
2018 | 29 | 30 | 59 |
2019 | 15 | 32 | 47 |
2020 | 29 | 43 | 72 |
2021 | 17 | 46 | 63 |
2022 | 4 | 57 | 61 |
2023 | 1 | 57 | 58 |
2024 | 11 | 19 | 30 |
2025 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammation" by people in Profiles.
-
Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge. Biomolecules. 2025 Apr 23; 15(5).
-
Glucose uptake in pigment glia suppresses Tau-induced inflammation and photoreceptor degeneration. Dis Model Mech. 2025 Apr 01; 18(4).
-
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer. Gut. 2025 Mar 06; 74(4):586-602.
-
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores. Respir Med. 2025 May; 241:108015.
-
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2025 Mar; 13(3):234-243.
-
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arterioscler Thromb Vasc Biol. 2025 Mar; 45(3):372-385.
-
Reverse transcriptase inhibitors diminish systemic proinflammatory responses to bacterial pathogens. mBio. 2025 Feb 05; 16(2):e0341224.
-
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup. Sci Transl Med. 2025 Jan; 17(779):eadr2012.
-
Associations of systemic immune-inflammation index and systemic inflammation response index with maternal gestational diabetes mellitus: Evidence from a prospective birth cohort study. Chin Med J (Engl). 2025 Mar 20; 138(6):729-737.
-
Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment. Cancer Immunol Res. 2024 Dec 03; 12(12):1736-1752.